Cinacalcet hydrochloride and Peritonitis - a phase IV clinical study of FDA data

Summary:

Peritonitis is reported as a side effect among people who take Cinacalcet hydrochloride (cinacalcet hydrochloride), especially for people who are female, 60+ old, also take Renagel, and have Hyperparathyroidism secondary.

The phase IV clinical study analyzes which people have Peritonitis when taking Cinacalcet hydrochloride. It is created by eHealthMe based on reports of 2,315 people who have side effects when taking Cinacalcet hydrochloride from the FDA, and is updated regularly.

What is Cinacalcet hydrochloride?

Cinacalcet hydrochloride has active ingredients of cinacalcet hydrochloride. eHealthMe is studying from 2,334 Cinacalcet hydrochloride users. Check the latest studies of Cinacalcet hydrochloride.

What is Peritonitis?

Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs) is found to be associated with 1,050 drugs and 1,576 conditions by eHealthMe. Check the latest studies of Peritonitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 31, 2026

2,315 people reported to have side effects when taking Cinacalcet hydrochloride.
Among them, 20 people (0.86%) have Peritonitis.

Could Cinacalcet hydrochloride cause Peritonitis?

Among these 20 people:

What is the gender of people who have Peritonitis when taking Cinacalcet hydrochloride? *

  • female: 56.25 %
  • male: 43.75 %

What is the age of people who have Peritonitis when taking Cinacalcet hydrochloride? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 25 %
  • 50-59: 25 %
  • 60+: 50 %

What are other drugs people take besides Cinacalcet hydrochloride? *

  1. Renagel: 6 people, 30.00%
  2. Extraneal: 4 people, 20.00%
  3. Vitamin D3: 4 people, 20.00%
  4. Aspirin: 4 people, 20.00%
  5. Envarsus Xr: 3 people, 15.00%
  6. Cephalexin: 3 people, 15.00%
  7. Nifedipine: 3 people, 15.00%
  8. Fosrenol: 3 people, 15.00%
  9. Bumetanide: 3 people, 15.00%
  10. Vitamin B12: 3 people, 15.00%

What are other side effects people have besides Peritonitis? *

  1. Diverticular Perforation (serious gastrointestinal condition in which the intestine's walls are perforated): 3 people, 15.00%
  2. Heart Disease: 3 people, 15.00%
  3. Gastrointestinal Perforation (hole in the digestive tract): 3 people, 15.00%
  4. Device Related Infection: 2 people, 10.00%
  5. Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 2 people, 10.00%
  6. Nausea (feeling of having an urge to vomit): 2 people, 10.00%
  7. Nausea And Vomiting: 2 people, 10.00%
  8. Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 2 people, 10.00%
  9. High Blood Pressure: 2 people, 10.00%
  10. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 10.00%

What are the existing conditions these people have? *

  1. Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 8 people, 40.00%
  2. Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 4 people, 20.00%
  3. Diabetic Nephropathy (diabetic kidney disease): 2 people, 10.00%
  4. Nephrogenic Anaemia (anaemia due to kidney disease): 1 person, 5.00%
  5. Gastric Ulcer (stomach ulcer): 1 person, 5.00%
  6. Back Pain: 1 person, 5.00%
  7. Blood Parathyroid Hormone Increased: 1 person, 5.00%
  8. Blood Phosphorus Abnormal: 1 person, 5.00%
  9. Chronic Kidney Disease: 1 person, 5.00%
  10. Chronic Renal Failure (kidney failure): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cinacalcet hydrochloride and have Peritonitis?

- Check whether Peritonitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cinacalcet hydrochloride:

Peritonitis treatments and more:

How severe was Peritonitis and when was it recovered:

Expand to all the drugs that have ingredients of cinacalcet hydrochloride:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cinacalcet hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Peritonitis:

Browse all the conditions that are associated with Peritonitis:


How the study uses the data?

The study uses data from the FDA. It is based on cinacalcet hydrochloride (the active ingredients of Cinacalcet hydrochloride) and Cinacalcet hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: